Repair or Replace: What Are We Learning From Real-World Studies?

Published: 02 December 2022

  • Views:

    Views Icon 5220
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

What are real-world studies telling us about selecting between repair or replace strategies for leaky valves? In this series of videos, we bring you up to date with how the dynamic is changing in favour of transcatheter approaches for a great number of patients, and provide some practical guidance for patient selection in both tricuspid and mitral regurgitation. We also explore how a rapidly accumulating body of real-world evidence is starting to shed light on new patient groups that stand to benefit from transcatheter strategies, and seek expert views from both a surgical and interventional perspective on the future success of these treatments.

Filmed following data released at PCR London Valves 2022, our faculty examine some of the latest real-world data on mitral and tricuspid regurgitation and put this data into context for practitioners.

This programme is supported by an educational grant from Abbott.


Learning Objectives

  • Describe the value of real-world data in the treatment of mitral and tricuspid regurgitation
  • Review how patient selection for repair or replacement strategies may change in the near future
  • Identify patient groups in whom transcatheter repair and replacement strategies may be preferable over surgical approaches
  • Understand the value of surgical teams for transcatheter valve interventions
  • Recall the latest real-world evidence on transcatheter repair and replacement treatments for tricuspid and mitral regurgitation

Target Audience

  • Interventional Cardiologists
  • Cardiac Surgeons
  • Heart Failure Specialists
  • General Cardiologists

More from this programme

Faculty Biographies

Maurizio Taramasso

Maurizio Taramasso

Specialist in cardiac surgery

Specialist in cardiac surgery since 2014, Dr Maurizio Taramasso has completed his surgical training at the San Raffaele University Hospital in Milan, Italy. He has also done specific cross-training in interventional cardiology and heart valve transcatheter therapies (mitral and aortic) at the San Raffaele University Hospital. His main areas of interest include surgical and catheter treatments of valvular heart disease (transfemoral and transapical TAVI, MitraClip) and heart failure. He is author and co-author of numerous publications on this topic.

View full profile